What is the Shree Ganesh Remedies Ltd share price today?

The share price of NSE:SGRL-EQ on 01 Oct 2026 (as of 15:04:50 IST) is ₹689.

What is the NSE:SGRL-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:SGRL-EQ 52 week high low range shows a high of ₹749.85 and a low of ₹477.05.

What is the Shree Ganesh Remedies Ltd market cap?

As on 01 Oct 2026, Shree Ganesh Remedies Ltd market cap is ₹8808530000.

What is the shareholding pattern of Shree Ganesh Remedies Ltd Stock?

The shareholding pattern of Shree Ganesh Remedies Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 72.84% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0.52% Mutual Funds: 0% Retail & Others: 26.64% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Shree Ganesh Remedies Ltd?

The Price-to-Earnings (PE) ratio of Shree Ganesh Remedies Ltd is 57.0686, and the Price-to-Book (PB) ratio is 3.3089, as on 01 Oct 2026.

Shree Ganesh Remedies Share Price

633.65+8.70 (+6.01%)

+29.20% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+6.01%

1 Week

+2.70%

1 Month

-7.08%

3 Month

-2.94%

6 Month

+19.42%

YTD

+36.80%

1 Year

+29.20%

5 Year

+72.49%

10 Year

NA

Max

+919.67%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

603.50

568.80

476.75

381.10

High

634.70

735.00

750.00

759.00

About

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

SGRL-BNSE

LTP

1W Low

1W High

Market cap (₹)

1771.95-6.3 (-0.35%)

1720.80

1854.80

4,24,202Cr

10030+315 (3.24%)

9622.85

10035

2,64,141Cr

4635-0.15 (-0.00%)

4555

4668.55

1,74,402Cr

2320-72 (-3.01%)

2207.10

2442

1,26,811Cr

1239-5 (-0.40%)

1184.55

1264.20

1,23,685Cr

1370+19.8 (1.47%)

1337.30

1390.70

1,11,868Cr

1392.2+12.2 (0.88%)

1360.60

1392.20

1,11,650Cr

2477.1-11.65 (-0.47%)

2457.35

2527.80

1,02,196Cr

1699+21.2 (1.26%)

1650.10

1699

96,951Cr

2012+3 (0.15%)

1974.05

2032

91,301Cr

633.65+16.65 (2.70%)

568.80

655

767Cr

Shree Ganesh Remedies Share Price

633.65+8.70 (+6.01%)

+29.20% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Shree Ganesh Remedies Share Price

633.65+8.70 (+6.01%)

+29.20% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years20%

Last year1%

Compounded Profit Growth

10 years-

5 years-

3 years19%

Last year-23%

Stock Price CAGR

10 years-

5 years11%

3 years9%

1 year27%

Return on Equity

10 years22%

5 years22%

3 years21%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	20%	1%
-	-	19%	-23%
-	11%	9%	27%
22%	22%	21%	12%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

SGRL-B

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,771.95	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,030	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,635	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,320	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,239	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,370	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,392.2	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,477.1	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,699	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,012	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
633.65	₹767 Cr	63.37	1.27	17.54	₹18 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2021	Sep 2021	Dec 2020	Sep 2020
₹23 Cr	₹14 Cr	₹33 Cr	₹21 Cr	₹30 Cr	₹25 Cr	₹24 Cr	₹27 Cr	₹32 Cr	₹25 Cr	₹37 Cr	₹21 Cr	₹17 Cr	₹13 Cr	₹12 Cr
₹1 Cr	₹94 L	₹1 Cr	₹66 L	₹69 L	₹66 L	₹2 Cr	₹71 L	₹19 L	₹55 L	₹1 Cr	₹88 L	₹44 L	₹55 L	₹45 L
₹25 Cr	₹15 Cr	₹34 Cr	₹22 Cr	₹31 Cr	₹25 Cr	₹27 Cr	₹28 Cr	₹33 Cr	₹25 Cr	₹39 Cr	₹22 Cr	₹17 Cr	₹14 Cr	₹12 Cr
₹22 Cr	₹13 Cr	₹25 Cr	₹17 Cr	₹23 Cr	₹20 Cr	₹17 Cr	₹20 Cr	₹23 Cr	₹19 Cr	₹22 Cr	₹16 Cr	₹13 Cr	₹10 Cr	₹8 Cr
₹5 Cr	₹4 Cr	₹12 Cr	₹7 Cr	₹10 Cr	₹8 Cr	₹12 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹18 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹5 Cr
₹58 L	₹32 L	₹88 L	₹74 L	₹1 Cr	₹94 L	₹97 L	₹39 L	₹44 L	₹32 L	₹15 L	₹3 L	₹3 L	₹2 L	₹1 L
₹2 Cr	₹2 Cr	₹9 Cr	₹4 Cr	₹7 Cr	₹5 Cr	₹9 Cr	₹8 Cr	₹9 Cr	₹6 Cr	₹16 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹4 Cr
₹2 Cr	₹1 Cr	₹6 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹7 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹13 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2020	Mar 2019
—	—	—	—	—
₹13 Cr	₹13 Cr	₹13 Cr	₹9 Cr	₹9 Cr
₹150 Cr	₹132 Cr	₹109 Cr	₹33 Cr	₹25 Cr
₹150 Cr	₹132 Cr	₹109 Cr	₹33 Cr	₹25 Cr
₹163 Cr	₹145 Cr	₹122 Cr	₹42 Cr	₹34 Cr
₹0	₹0	₹0	₹4 L	₹0
₹21 Cr	₹29 Cr	₹29 Cr	₹4 L	₹24 L
₹0	₹0	₹0	₹2 Cr	₹0
₹1 Cr	₹53 L	₹58 L	₹28 L	₹33 L
₹13 L	₹13 L	₹12 L	₹0	₹0
₹57 L	₹46 L	₹33 L	₹18 L	₹16 L
₹23 Cr	₹31 Cr	₹30 Cr	₹3 Cr	₹73 L
—	—	—	—	—
₹9 Cr	₹6 Cr	₹8 Cr	₹5 Cr	₹4 Cr
₹12 Cr	₹10 Cr	₹8 Cr	₹20 L	₹18 L
₹2 L	₹2 L	₹71 L	₹2 Cr	₹33 L
₹6 Cr	₹8 Cr	₹9 Cr	₹4 Cr	₹2 Cr
₹27 Cr	₹24 Cr	₹26 Cr	₹10 Cr	₹7 Cr
₹213 Cr	₹200 Cr	₹178 Cr	₹55 Cr	₹41 Cr
₹2 Cr	₹5 Cr	₹5 Cr	₹0	₹0
₹31 Cr	₹38 Cr	₹36 Cr	₹4 Cr	₹75 L
—	—	—	—	—
₹148 Cr	₹128 Cr	₹105 Cr	₹29 Cr	₹21 Cr
₹43 Cr	₹33 Cr	₹25 Cr	₹9 Cr	₹7 Cr
₹105 Cr	₹95 Cr	₹81 Cr	₹20 Cr	₹14 Cr
₹12 Cr	₹8 Cr	₹17 Cr	₹0	₹0
₹8 L	₹8 L	₹8 L	₹7 L	₹5 L
₹8 L	₹8 L	₹8 L	₹7 L	₹5 L
₹4 Cr	₹11 Cr	₹3 Cr	₹1 Cr	₹72 L
₹4 L	₹20,000	₹50,000	₹20 L	₹27 L
₹122 Cr	₹114 Cr	₹101 Cr	₹21 Cr	₹16 Cr
—	—	—	—	—
₹12 Cr	₹18 Cr	₹5 Cr	₹3 Cr	₹4 Cr
₹24 Cr	₹22 Cr	₹25 Cr	₹6 Cr	₹7 Cr
₹33 Cr	₹22 Cr	₹20 Cr	₹18 Cr	₹10 Cr
₹13 Cr	₹10 Cr	₹16 Cr	₹2 Cr	₹100 L
₹1 Cr	₹1 Cr	₹80 L	₹0	₹0
₹7 Cr	₹12 Cr	₹10 Cr	₹4 Cr	₹5 Cr
₹91 Cr	₹86 Cr	₹77 Cr	₹34 Cr	₹26 Cr
₹64 Cr	₹61 Cr	₹52 Cr	₹23 Cr	₹19 Cr
₹213 Cr	₹200 Cr	₹178 Cr	₹55 Cr	₹41 Cr
₹127	₹113	₹95	₹47	₹38
₹127	₹113	₹95	₹35	₹28

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2020	Mar 2019
₹24 Cr	₹31 Cr	₹38 Cr	₹14 Cr	₹9 Cr
₹12 Cr	₹11 Cr	₹6 Cr	-₹4 Cr	-₹35 L
-₹7 Cr	-₹2 Cr	-₹5 Cr	-₹5 Cr	-₹14 Cr
₹29 Cr	₹41 Cr	₹39 Cr	₹5 Cr	-₹5 Cr
₹24 Cr	₹31 Cr	₹30 Cr	₹5 Cr	-₹5 Cr
-₹10 Cr	-₹36 Cr	-₹33 Cr	-₹3 Cr	-₹8 L
-₹12 Cr	-₹1 Cr	₹10 Cr	-₹48 L	-₹18 L
₹2 Cr	-₹6 Cr	₹7 Cr	₹1 Cr	-₹5 Cr
₹10 Cr	₹16 Cr	₹9 Cr	₹1 Cr	₹6 Cr
₹1 Cr	₹18 L	-₹8 L	₹0	₹0
₹13 Cr	₹10 Cr	₹16 Cr	₹2 Cr	₹99 L

Fundamental Ratios

Consolidated

Standalone

No results found

Shree Ganesh Remedies Share Price

633.65+8.70 (+6.01%)

+29.20% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Shree Ganesh Remedies Share Price

633.65+8.70 (+6.01%)

+29.20% past 1 Year

Shareholding summary

Promoters

72.84%

FII

0%

DII

0.99%

MF

0%

Others

26.17%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
72.84%	72.84%	72.84%	72.80%	72.80%	72.80%
0.00%	0.00%	0.00%	0.00%	0.01%	0.01%
0.99%	0.52%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
26.17%	26.64%	27.16%	27.20%	27.19%	27.19%

Bulk & block deals

Name

Nilesh Mansukhbhai Patel

Madras Parameswaran Manoj Mahadev

Nnm Securities Pvt Ltd

Khyani Harshil

Girraj Kishor Agarwal (Huf)

Nnm Securities Pvt Ltd

Miker Financial Consultants Private Limited

Rikhav Securities Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
16 Feb 2021	Sell	1.73 Cr	₹218.70	78.97 K	Bulk	0.61517	BSE
09 Nov 2020	Purchase	1.17 Cr	₹140.46	83.65 K	Bulk	0.651602	BSE
07 Oct 2019	Sell	35.06 L	₹68.75	51 K	Bulk	0.397271	BSE
07 Oct 2019	Purchase	35.06 L	₹68.75	51 K	Bulk	0.397271	BSE
27 Mar 2019	Purchase	53.76 L	₹68.92	78 K	Bulk	0.60759	BSE
27 Mar 2019	Sell	55.61 L	₹68.65	81 K	Bulk	0.630959	BSE
27 Mar 2019	Purchase	1.74 L	₹58	3 K	Bulk	0.023369	BSE
06 Feb 2019	Purchase	23 L	₹51.10	45 K	Bulk	0.350533	BSE
15 Jan 2019	Sell	23.04 L	₹51.20	45 K	Bulk	0.350533	BSE
31 Dec 2018	Sell	30.58 L	₹50.97	60 K	Bulk	0.467377	BSE

Insider trading & SAST

Client name

Chandrakant Koladiya

Parth Chandulal Kothia

Chandrakant Koladiya

Parth Chandulal Kothia

Hemali Varun Jadafiya

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
20 Feb 2026	Promoters Immediate Relative	Acquisition	0.015579	0.12	10.14 L	₹507.24	2 K	16 Feb 2026	Market Purchase	15,534	Insider Trading	—	Equity Shares
16 Feb 2026	Promoters Immediate Relative	Acquisition	0.009355	0.11	6.17 L	₹513.52	1.20 K	13 Feb 2026	Market Purchase	13,534	Insider Trading	—	Equity Shares
16 Feb 2026	Promoters Immediate Relative	Acquisition	0.010991	0.1	7.15 L	₹506.46	1.41 K	11 Feb 2026	Market Purchase	12,333	Insider Trading	—	Equity Shares
16 Feb 2026	Promoter	Acquisition	0.006029	1.06	4 L	₹516.54	774	13 Feb 2026	Market Purchase	1,36,689	Insider Trading	—	Equity Shares
11 Feb 2026	Promoters Immediate Relative	Acquisition	0.00779	0.07	4.80 L	₹479.89	1 K	09 Feb 2026	Market Purchase	9,521	Insider Trading	—	Equity Shares
11 Feb 2026	Promoters Immediate Relative	Acquisition	0.006232	0.07	3.72 L	₹464.91	800	06 Feb 2026	Market Purchase	8,521	Insider Trading	—	Equity Shares
11 Feb 2026	Promoters Immediate Relative	Acquisition	0.010913	0.09	7.01 L	₹500.21	1.40 K	10 Feb 2026	Market Purchase	10,922	Insider Trading	—	Equity Shares
09 Feb 2026	Promoters Immediate Relative	Acquisition	0.00779	0.06	4.53 L	₹452.86	1 K	05 Feb 2026	Market Purchase	7,721	Insider Trading	—	Equity Shares
09 Feb 2026	Promoter	Acquisition	0.022348	1.06	13.06 L	₹455.19	2.87 K	05 Feb 2026 - 09 Feb 2026	Market Purchase	1,35,915	Insider Trading	—	Equity Shares
05 Feb 2026	Employees Immediate Relative	Acquisition	0.000849	0	49.59 K	₹454.95	109	03 Feb 2026	Market Purchase	109	Insider Trading	—	Equity Shares

Shree Ganesh Remedies Share Price

633.65+8.70 (+6.01%)

+29.20% past 1 Year

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to

Corporate Actions

Date

Type

Details

2023-09-07

Dividend

0.5

2023-02-03

Rights

7:100;215.0

Company details

Registered office

Plot No. 6002, 6003, 6011 & 6012 G. I. D. C. Bharuch Ankleshwar Gujarat PIN: 393002 Tel No: 07574 976076 / 9614961469 Fax No: NULL Email: [email protected] Internet: www.ganeshremedies.com

Registrars

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]

Management

Akanksha, Company Secretary and Compliance Officer

Chandulal Manubhai Kothia, Chairman & Managing Director

Parth Chandulal Kothia, Whole Time Director & Chief Financial Officer

Maulikkumar Sudani, Non Executive Independent Director

Parulben Sahani, Non Executive Independent Director

Shruti Rajesh Sohane, Non Executive Independent Director

Hiral Ankitkumar Shah, Non Executive Independent Director

Details

BSE 540737

NSE SGRL

ISIN INE414Y01015